W358509
L-フェニルアラニン
99%, FCC
別名:
(S)-2-アミノ-3-フェニルプロピオン酸
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
化学式:
C6H5CH2CH(NH2)CO2H
CAS番号:
分子量:
165.19
FEMA Number:
3585
Council of Europe no.:
10488
UNSPSC Code:
12164502
PubChem Substance ID:
NACRES:
NA.21
EC Number:
200-568-1
Flavis number:
17.018
MDL number:
Beilstein/REAXYS Number:
1910408
eCl@ss:
32160406
Organoleptic:
odorless
Grade:
Kosher
Biological source:
synthetic
Agency:
meets purity specifications of JECFA
Food allergen:
no known allergens
biological source
synthetic
grade
Kosher
agency
meets purity specifications of JECFA
reg. compliance
FCC, FDA 21 CFR 172.320
assay
99%
optical activity
[α]25/D -34.2°, c = 2 in H2O (dried basis)
mp
270-275 °C (dec.) (lit.)
solubility
H2O: soluble 16.5 g/L at 20 °C (completely)
application(s)
flavors and fragrances
documentation
see Safety & Documentation for available documents
food allergen
no known allergens
organoleptic
odorless
SMILES string
N[C@@H](Cc1ccccc1)C(O)=O
InChI
1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1
InChI key
COLNVLDHVKWLRT-QMMMGPOBSA-N
Disclaimer
For R&D or non-EU Food use. Not for retail sale.
Still not finding the right product?
Explore all of our products under L-フェニルアラニン
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
関連コンテンツ
Ann Mullally et al.
Blood, 121(18), 3692-3702 (2013-03-15)
Interferon-α (IFNα) is an effective treatment of patients with myeloproliferative neoplasms (MPNs). In addition to inducing hematological responses in most MPN patients, IFNα reduces the JAK2V617F allelic burden and can render the JAK2V617F mutant clone undetectable in some patients. The
Vimesh A Avlani et al.
American journal of physiology. Endocrinology and metabolism, 304(10), E1097-E1104 (2013-03-28)
In addition to its acute effects on hormone secretion, epithelial transport, and shape change, the calcium-sensing receptor (CaSR) modulates the expression of genes that control cell survival, proliferation, and differentiation as well as the synthesis of peptide hormones and enzymes.
Stefanie Keil et al.
Pediatrics, 131(6), e1881-e1888 (2013-05-22)
Sapropterin dihydrochloride, the synthetic form of 6R-tetrahydrobiopterin (BH4), is an approved drug for the treatment of patients with BH4-responsive phenylketonuria (PKU). The purpose of this study was to assess genotypes and data on the long-term effects of BH4/sapropterin on metabolic